Rethinking Trial Access in Lower-Income Regions
Expanding breast cancer research leadership beyond high-income countries can be achieved through technology and mindset shifts, building more inclusive global trial networks.
In a recent video interview with Applied Clinical Trials, Gen Li, PhD, MBA, president of Phesi, discussed the company's analysis on global inequity in breast cancer development.
He highlighted the geographic concentration of breast cancer trial leaders in the US and China, with a positive outlook on global diversity.
Li attributed operational barriers in lower-income countries to traditional business models, emphasizing the need for a more patient-centric approach using artificial intelligence (AI) and machine learning.
- Identifying local leaders to address the lack of local KOLs in underserved areas
- Redistributing trial workloads and improving recruitment using AI to identify and activate new sites
Author's summary: AI-driven models can help expand breast cancer research.